|
Atara Biotherapeutics Inc (NASDAQ: ATRA) |
|
Atara Biotherapeutics Inc
ATRA's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Atara Biotherapeutics Inc growth rates, revenue grew
by 928.14 % in IV. Quarter 2024 from the same quarter a year ago.
Ranking at No. 90
Biotechnology & Pharmaceuticals industry recorded
deterioration of revenues by -2.45 %
Atara Biotherapeutics Inc net loss decreased from $-60 millions, to $-13 millions in IV. Quarter 2024,
• More on ATRA's Growth
|
|
Atara Biotherapeutics Inc realized a net loss in trailing twelve months.
Atara Biotherapeutics Inc realized cash reduction of $ -0.11 per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.17.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.02.
• More on ATRA's Valuation
|
|
|
|
|
Atara Biotherapeutics Inc realized net loss in trailing twelve months.
Atara Biotherapeutics Inc realized cash outflow of $ -0.11per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.17.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.02.
• More on ATRA's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com